These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9000650

  • 1. Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium.
    Okuda Y, Kawashima K, Suzuki S, Asakura Y, Asano M, Tsurumaru K, Dai H, Tachi Y, Bannai C, Saitoh M, Yamashita K.
    Life Sci; 1997; 60(3):PL53-6. PubMed ID: 9000650
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules.
    Okayama N, Omi H, Okouchi M, Imaeda K, Kato T, Akao M, Imai S, Shimizu M, Fukutomi T, Itoh M.
    J Diabetes Complications; 2002; 16(5):321-6. PubMed ID: 12200074
    [Abstract] [Full Text] [Related]

  • 3. Effect of glucose and an aldose reductase inhibitor on myo-inositol uptake by cultured human endothelial cells.
    Okuda Y, Bannai C, Nagahama M, Mizutani M, Mitsui Y, Yamashita K.
    Diabetes Res; 1991 Oct; 18(2):61-4. PubMed ID: 1841813
    [Abstract] [Full Text] [Related]

  • 4. Decreased production of nitric oxide by LPS-treated J774 macrophages in high-glucose medium.
    Tseng CC, Hattori Y, Kasai K, Nakanishi N, Shimoda S.
    Life Sci; 1997 Oct; 60(7):PL99-106. PubMed ID: 9042381
    [Abstract] [Full Text] [Related]

  • 5. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
    Ishibashi Y, Matsui T, Matsumoto T, Kato H, Yamagishi S.
    Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
    [Abstract] [Full Text] [Related]

  • 6. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.
    Hotta N, Kakuta H, Koh N, Fukasawa H, Yasuma T, Awaya S, Sakamoto N.
    Diabetes Res Clin Pract; 1991 Oct; 14(1):29-35. PubMed ID: 1748061
    [Abstract] [Full Text] [Related]

  • 7. Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of protein glycation in vitro.
    Takeda H, Higashi T, Nishikawa T, Sato Y, Anami Y, Yano T, Kasho M, Kobori S, Shichiri M.
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):1-8. PubMed ID: 8792096
    [Abstract] [Full Text] [Related]

  • 8. Restoration of myo-inositol uptake by aldose reductase inhibitor in human skin fibroblasts cultured in high-glucose medium.
    Okuda Y, Bannai C, Nagahama M, Isaka M, Yamashita K.
    Horm Metab Res; 1991 Jan; 23(1):42-3. PubMed ID: 1901824
    [No Abstract] [Full Text] [Related]

  • 9. Polyol pathway in tissues of spontaneously diabetic Chinese hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235.
    Sekiguchi M, Watanabe K, Eto M, Iwashima Y, Morikawa A, Takahashi M, Ishii K, Makino I.
    Comp Biochem Physiol B; 1991 Jan; 98(4):637-40. PubMed ID: 1907900
    [Abstract] [Full Text] [Related]

  • 10. Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
    Senthilkumari S, Sharmila R, Chidambaranathan G, Vanniarajan A.
    J Ocul Pharmacol Ther; 2017 Jan; 33(1):34-41. PubMed ID: 27835059
    [Abstract] [Full Text] [Related]

  • 11. An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-beta receptor in cultured rat aortic smooth muscle cells.
    Kasuya Y, Nakamura J, Hamada Y, Nakayama M, Sasaki H, Komori T, Chaya S, Watanabe G, Naruse K, Nakashima E, Kato K, Hotta N.
    Biochem Biophys Res Commun; 1999 Aug 11; 261(3):853-8. PubMed ID: 10441515
    [Abstract] [Full Text] [Related]

  • 12. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells.
    Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S, Soma M, Nakajima T, Yamashita K.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):487-91. PubMed ID: 9125207
    [Abstract] [Full Text] [Related]

  • 13. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Hatanaka I, Shigeta Y.
    J Pharmacol Exp Ther; 1984 Apr 17; 229(1):226-30. PubMed ID: 6423811
    [Abstract] [Full Text] [Related]

  • 14. Effects of aldose reductase inhibitor (ONO-2235) on human erythrocyte sorbitol concentrations in 75 g oral glucose tolerance tests.
    Kamon N, Mabuchi H, Takeda R, Terashima H.
    Horm Metab Res; 1991 May 17; 23(5):226-9. PubMed ID: 1908433
    [Abstract] [Full Text] [Related]

  • 15. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation.
    El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RB.
    Invest Ophthalmol Vis Sci; 2003 Jul 17; 44(7):3135-43. PubMed ID: 12824263
    [Abstract] [Full Text] [Related]

  • 16. Effect of aldose reductase inhibition on interleukin-1beta-induced nitric oxide (NO) synthesis in vascular tissue.
    Morales J, Dunbar JC, Ram JL.
    Int J Exp Diabetes Res; 2002 Jul 17; 3(1):11-20. PubMed ID: 11900276
    [Abstract] [Full Text] [Related]

  • 17. Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes.
    Kanda M, Eto K, Tanabe N, Sugiyama A, Hashimoto K, Ueno A.
    Jpn J Pharmacol; 1997 Mar 17; 73(3):221-8. PubMed ID: 9127817
    [Abstract] [Full Text] [Related]

  • 18. [Protective effect of epalrestat against high glucose-induced endothelial cell injuries].
    Wang F, Hong Q, Liu G.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun 17; 32(7):940-3. PubMed ID: 22820572
    [Abstract] [Full Text] [Related]

  • 19. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
    Kato K, Nakayama K, Mizota M, Miwa I, Okuda J.
    Chem Pharm Bull (Tokyo); 1991 Jun 17; 39(6):1540-5. PubMed ID: 1934175
    [Abstract] [Full Text] [Related]

  • 20. Aldose reductase inhibitor Epalrestat alleviates high glucose-induced cardiomyocyte apoptosis via ROS.
    Wang X, Yu F, Zheng WQ.
    Eur Rev Med Pharmacol Sci; 2019 Aug 17; 23(3 Suppl):294-303. PubMed ID: 31389594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.